Article Details

POINT Biopharma Receives US Nuclear Regulatory Commission Materials License for Indiana ...

Retrieved on: 2021-06-01 20:37:30

Tags for this article:

Click the tags to see associated articles and topics

POINT Biopharma Receives US Nuclear Regulatory Commission Materials License for Indiana .... View article details on hiswai:

Excerpt

POINT Biopharma Inc. (POINT), a radiopharmaceutical company dedicated to bringing the many benefits of precision radioligand therapy to cancer ...

Article found on: finance.yahoo.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up